Clinical

Dataset Information

0

Exploratory study for prevention of nausea and vomiting switching from Granisetron + Dexamethasone (Day1-3) + Aprepitant (Day1-3) to Palonosetron + Dexamethasone (Day1) in patients given moderately emetogenic chemotherapy

ABSTRACT: Interventions: GRA+DEX (Day1-3)+APR(Day1-3) PALO+DEX(Day1) Primary outcome(s): Nausea (Overall study period) Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2636857 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Unknown Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting.
| S-EPMC7373869 | biostudies-literature
Unknown Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial.
| S-EPMC9167865 | biostudies-literature
Unknown Comparative effectiveness of netupitant-palonosetron plus dexamethasone versus aprepitant-based regimens in mitigating chemotherapy-induced nausea and vomiting: a meta-analysis of randomized controlled trials.
| S-EPMC11886791 | biostudies-literature
Unknown Aprepitant plus palonosetron for the prevention of postoperative nausea and vomiting after breast cancer surgery: a double blind, randomized trial.
| S-EPMC7454124 | biostudies-literature
Unknown A Randomized Controlled Trial for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Sleeve Gastrectomy: Aprepitant/Dexamethasone vs. Mirtazapine/Dexamethasone.
| S-EPMC9078838 | biostudies-literature
Unknown Efficacy of Palonosetron-Dexamethasone Combination Versus Palonosetron Alone for Preventing Nausea and Vomiting Related to Opioid-Based Analgesia: A Prospective, Randomized, Double-blind Trial.
| S-EPMC6036163 | biostudies-literature
Unknown Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting.
| S-EPMC8463343 | biostudies-literature
Transcriptomics Area postrema cell types that mediate nausea-associated behaviors
2020-12-07 | GSE160938 | GEO
Unknown Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomiting.
| S-EPMC9607815 | biostudies-literature
Unknown Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial.
| S-EPMC7794169 | biostudies-literature